Our data show that NAMPT‐deficient TAMs initiate a higher levels of effector T cells (CD44highCD72Llow), suggesting that inhibition of NAMPT improves anti‐tumor immunity by enhancing cytotoxic T cell function. Here, NAMPT is linked to neoplasm.